The influence of genetics on response to treatment with ranibizumab (Lucentis) for age-related macular degeneration: the Lucentis Genotype Study (an American Ophthalmological Society thesis).
Transactions of the American Ophthalmological Society 2011 Dec 109 115-56.
Francis Peter Jam
- Page last reviewed:Mar 1, 2018
- Page last updated:Jun 13, 2019
- Content source: